A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention (ARISE-Study)
Jun 1, 2015
To evaluate the effect of AMG 334 compared to placebo on the change from baseline in monthly migraine days, in subjects with episodic migraine
Clinical Studies -
Jun 1, 2015 - Dec 31, 2017
Automatically Closed
Project leader: Flügel Dominique
Members: Zieglgänsberger Dominik, Müller Anna
more